GSK717
|
|
|
- CAS号:
- 1595278-21-9
- 英文名:
- GSK717
- 英文别名:
- GSK717;1H-Benzimidazole-1-acetamide, 2-[2-(benzoylmethylamino)ethyl]-N-(2,3-dihydro-1H-inden-5-yl)-;N-(2-(1-(2-((2,3-Dihydro-1H-inden-5-yl)amino)-2-oxoethyl)-1H-benzo[d]imidazol-2-yl)ethyl)-N-methylbenzamide;immune,GSK717,inhibit,Inhibitor,NOD2-TLR2,pro-inflammatory,MDP-stimulated,NOD-like Receptor (NLR),responses,cytokines,synergy,GSK 717,GSK-717
- 中文名:
- GSK717
- 中文别名:
- 化合物GSK717;N-(2-(1-(2-((2,3-二氢-1H-茚-5-基)氨基)-2-氧代乙基)-1H-苯并[D]咪唑-2-基)乙基)-N-甲基苯甲酰胺
- CBNumber:
- CB77243681
- 分子式:
- C28H28N4O2
- 分子量:
- 452.56
- MOL File:
- 1595278-21-9.mol
|
|
|
GSK717化学性质
-
沸点:
-
731.6±60.0 °C(Predicted)
-
|
-
密度:
-
1.23±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO: 250 mg/mL (552.43 mM)
-
|
-
酸度系数(pKa):
-
14.05±0.20(Predicted)
-
|
GSK717性质、用途与生产工艺
GSK717 是一种有效的、选择性的 NOD2 (核苷酸结合寡聚结构域 2) 抑制剂。GSK717 抑制壁酰二肽 (MDP) 诱导的 NOD2 介导的信号转导，抑制 MDP 刺激的 HEK293/hNOD2 细胞分泌 IL-8 中的 IC50 为 400 nM。
GSK717 blocks synergy between NOD2 and TLR2. GSK717 does not affect NOD1, TNFR1 and TLR2-mediated responses. GSK717 (5 μM) inhibits the release of IL-8, IL-6, TNFα and IL-1β in primary human monocytes stimulated with MDP.
GSK717
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/04/30 | HY-136555 | GSK717 | | 1 mg | 545元 |
| 2024/04/30 | HY-136555 | N-(2-(1-(2-((2,3-二氢-1H-茚-5-基)氨基)-2-氧代乙基)-1H-苯并[D]咪唑-2-基)乙基)-N-甲基苯甲酰胺
GSK717 | 1595278-21-9 | 5mg | 1200元 |
1595278-21-9, GSK717 相关搜索:
- 化合物GSK717
- N-(2-(1-(2-((2,3-二氢-1H-茚-5-基)氨基)-2-氧代乙基)-1H-苯并[D]咪唑-2-基)乙基)-N-甲基苯甲酰胺
- 1595278-21-9
- immune,GSK717,inhibit,Inhibitor,NOD2-TLR2,pro-inflammatory,MDP-stimulated,NOD-like Receptor (NLR),responses,cytokines,synergy,GSK 717,GSK-717
- N-(2-(1-(2-((2,3-Dihydro-1H-inden-5-yl)amino)-2-oxoethyl)-1H-benzo[d]imidazol-2-yl)ethyl)-N-methylbenzamide
- 1H-Benzimidazole-1-acetamide, 2-[2-(benzoylmethylamino)ethyl]-N-(2,3-dihydro-1H-inden-5-yl)-
- GSK717